Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

1.7%

1 terminated out of 58 trials

Success Rate

92.9%

+6.3% vs benchmark

Late-Stage Pipeline

5%

3 trials in Phase 3/4

Results Transparency

46%

6 of 13 completed with results

Key Signals

6 with results93% success

Data Visualizations

Phase Distribution

37Total
Not Applicable (11)
Early P 1 (1)
P 1 (3)
P 2 (19)
P 3 (3)

Trial Status

Recruiting19
Unknown18
Completed13
Not Yet Recruiting5
Active Not Recruiting2
Terminated1

Trial Success Rate

92.9%

Benchmark: 86.6%

Based on 13 completed trials

Clinical Trials (58)

Showing 20 of 20 trials
NCT07667400Phase 1Not Yet Recruiting

Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer

NCT06627270Phase 2RecruitingPrimary

Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer

NCT01772706Not ApplicableCompletedPrimary

Laser Mucite ORL : Effectiveness of Laser Therapy for Mucositis Induced by a Radio-chemotherapy in Head and Neck Cancer

NCT06055868Recruiting

People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity

NCT07654647Not ApplicableRecruiting

Clinical Evaluation of Patient-Specific 3D-Printed Titanium Implants for Facial Reconstruction.

NCT05791149Not ApplicableRecruitingPrimary

Epigenetic Biomarkers in the Saliva for the Diagnosis of Squamous Cells Carcinoma of the Oral Cavity

NCT05893888Phase 2RecruitingPrimary

A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers

NCT06876038Phase 2Not Yet Recruiting

Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions

NCT06336941Not ApplicableRecruitingPrimary

"Ultra-High Frequency intraOral UltraSonography of the TONgue" (HOUSTON)

NCT07063212Phase 2Recruiting

A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)

NCT05551117Phase 2Terminated

A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors

NCT07343271RecruitingPrimary

Dual-energy CT vs. MRI in the Evaluation of Squamous Cell Carcinomas of the Oral Cavity and Oropharynx

NCT06009861Phase 2Active Not RecruitingPrimary

Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (NeoSPOT)

NCT06321003RecruitingPrimary

SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography

NCT06258811Phase 3RecruitingPrimary

Neoadjuvant Immunochemotherapy for LAOSCC

NCT06174428Recruiting

Validity of Viome's Oral/throat Cancer Test

NCT05451303RecruitingPrimary

Detection of Oral and Throat Cancers Using OralViome Cancer Testing System

NCT04883645Early Phase 1CompletedPrimary

Neoadjuvant Imiquimod Immunotherapy for Oral Cancer

NCT04649476Phase 2CompletedPrimary

Neoadjuvant PD-1 Blockade in Resectable Oral Squamous Cell Carcinoma

NCT06031337Completed

Salivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy Study

Scroll to load more

Research Network

Activity Timeline